Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Small Interfering | 18 | 2025 | 908 | 2.120 |
Why?
|
| RNA Interference | 7 | 2025 | 618 | 0.970 |
Why?
|
| Drug Delivery Systems | 2 | 2018 | 326 | 0.810 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2018 | 103 | 0.540 |
Why?
|
| Huntingtin Protein | 4 | 2022 | 143 | 0.450 |
Why?
|
| Prodrugs | 1 | 2014 | 36 | 0.440 |
Why?
|
| Lipids | 3 | 2019 | 316 | 0.380 |
Why?
|
| Oligonucleotides | 4 | 2021 | 219 | 0.370 |
Why?
|
| Huntington Disease | 2 | 2022 | 154 | 0.340 |
Why?
|
| Central Nervous System | 2 | 2024 | 197 | 0.330 |
Why?
|
| Animals | 17 | 2025 | 20640 | 0.260 |
Why?
|
| Tissue Distribution | 4 | 2019 | 293 | 0.250 |
Why?
|
| HeLa Cells | 5 | 2019 | 533 | 0.240 |
Why?
|
| Mice | 14 | 2025 | 10832 | 0.240 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2025 | 144 | 0.220 |
Why?
|
| Dystrophin | 1 | 2023 | 31 | 0.210 |
Why?
|
| Nucleic Acids | 1 | 2024 | 60 | 0.210 |
Why?
|
| Acetylgalactosamine | 2 | 2024 | 10 | 0.200 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2023 | 41 | 0.200 |
Why?
|
| Cholesterol | 3 | 2019 | 259 | 0.200 |
Why?
|
| Gene Silencing | 5 | 2025 | 394 | 0.190 |
Why?
|
| Cells, Cultured | 4 | 2018 | 2156 | 0.180 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2021 | 84 | 0.170 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2017 | 100 | 0.170 |
Why?
|
| Genetic Therapy | 3 | 2023 | 780 | 0.170 |
Why?
|
| High-Throughput Screening Assays | 2 | 2017 | 78 | 0.160 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2025 | 503 | 0.160 |
Why?
|
| Liver | 5 | 2024 | 847 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 3 | 2024 | 3394 | 0.150 |
Why?
|
| Aptamers, Nucleotide | 1 | 2018 | 23 | 0.150 |
Why?
|
| Extracellular Vesicles | 1 | 2018 | 45 | 0.140 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 720 | 0.130 |
Why?
|
| RNA | 2 | 2023 | 423 | 0.130 |
Why?
|
| Genome, Human | 1 | 2018 | 237 | 0.130 |
Why?
|
| Guanabenz | 1 | 2015 | 3 | 0.120 |
Why?
|
| Exosomes | 1 | 2016 | 48 | 0.120 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 1615 | 0.120 |
Why?
|
| Humans | 14 | 2025 | 62905 | 0.120 |
Why?
|
| Peptides | 1 | 2018 | 577 | 0.110 |
Why?
|
| Gene Editing | 1 | 2018 | 310 | 0.110 |
Why?
|
| Apolipoproteins E | 2 | 2024 | 109 | 0.110 |
Why?
|
| Kidney | 3 | 2019 | 444 | 0.090 |
Why?
|
| Genetic Vectors | 1 | 2018 | 860 | 0.090 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 3 | 2019 | 261 | 0.090 |
Why?
|
| Argonaute Proteins | 1 | 2013 | 135 | 0.090 |
Why?
|
| Mice, Transgenic | 2 | 2025 | 1273 | 0.090 |
Why?
|
| Alleles | 2 | 2022 | 449 | 0.090 |
Why?
|
| Neurons | 1 | 2016 | 920 | 0.080 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2023 | 142 | 0.080 |
Why?
|
| Phosphorylcholine | 2 | 2019 | 44 | 0.070 |
Why?
|
| Nucleosides | 1 | 2007 | 11 | 0.070 |
Why?
|
| Ionic Liquids | 1 | 2007 | 8 | 0.070 |
Why?
|
| Hepatocytes | 2 | 2019 | 217 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 2182 | 0.060 |
Why?
|
| Female | 4 | 2019 | 32578 | 0.060 |
Why?
|
| Antagomirs | 1 | 2024 | 6 | 0.060 |
Why?
|
| Amyloidogenic Proteins | 1 | 2024 | 13 | 0.060 |
Why?
|
| Mice, Inbred mdx | 1 | 2023 | 15 | 0.050 |
Why?
|
| Apolipoprotein E4 | 1 | 2024 | 46 | 0.050 |
Why?
|
| Luciferases, Firefly | 2 | 2014 | 18 | 0.050 |
Why?
|
| Motor Neurons | 1 | 2025 | 212 | 0.050 |
Why?
|
| Superoxide Dismutase | 1 | 2025 | 227 | 0.050 |
Why?
|
| Amyloid | 1 | 2024 | 69 | 0.050 |
Why?
|
| Chemical Engineering | 1 | 2022 | 9 | 0.050 |
Why?
|
| Exons | 1 | 2023 | 199 | 0.050 |
Why?
|
| Drug Administration Routes | 1 | 2021 | 21 | 0.050 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2021 | 12 | 0.050 |
Why?
|
| RNAi Therapeutics | 1 | 2021 | 11 | 0.050 |
Why?
|
| Organophosphonates | 1 | 2021 | 22 | 0.050 |
Why?
|
| Amyloid beta-Peptides | 1 | 2024 | 297 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2021 | 80 | 0.050 |
Why?
|
| Sheep | 1 | 2021 | 179 | 0.050 |
Why?
|
| Fibrosis | 1 | 2021 | 159 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2019 | 1535 | 0.040 |
Why?
|
| Mutation | 2 | 2019 | 2601 | 0.040 |
Why?
|
| Triglycerides | 1 | 2021 | 244 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2022 | 424 | 0.040 |
Why?
|
| Receptors, LDL | 1 | 2019 | 34 | 0.040 |
Why?
|
| Lipoproteins, LDL | 1 | 2019 | 45 | 0.040 |
Why?
|
| Carbocyanines | 1 | 2019 | 29 | 0.040 |
Why?
|
| Blood Proteins | 1 | 2019 | 76 | 0.040 |
Why?
|
| Solid-Phase Synthesis Techniques | 1 | 2018 | 3 | 0.040 |
Why?
|
| Propylene Glycols | 1 | 2018 | 9 | 0.040 |
Why?
|
| Organophosphorus Compounds | 1 | 2018 | 31 | 0.040 |
Why?
|
| Macromolecular Substances | 1 | 2018 | 160 | 0.040 |
Why?
|
| Genetic Loci | 1 | 2018 | 115 | 0.040 |
Why?
|
| Peptide Nucleic Acids | 1 | 2017 | 16 | 0.040 |
Why?
|
| Docosahexaenoic Acids | 1 | 2017 | 31 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2019 | 200 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2024 | 676 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2017 | 189 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2019 | 198 | 0.030 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2018 | 97 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 617 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2018 | 493 | 0.030 |
Why?
|
| Brain | 1 | 2024 | 1555 | 0.030 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 58 | 0.030 |
Why?
|
| Photolysis | 1 | 2014 | 16 | 0.030 |
Why?
|
| Inflammation | 1 | 2021 | 1143 | 0.030 |
Why?
|
| Polystyrenes | 1 | 2014 | 33 | 0.030 |
Why?
|
| Biological Transport | 1 | 2015 | 293 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2015 | 370 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 201 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2014 | 136 | 0.030 |
Why?
|
| Obesity | 1 | 2021 | 1232 | 0.030 |
Why?
|
| Male | 2 | 2024 | 29585 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 670 | 0.020 |
Why?
|
| Binding Sites | 1 | 2013 | 903 | 0.020 |
Why?
|
| Base Sequence | 1 | 2013 | 1333 | 0.020 |
Why?
|